Nasopharyngeal extranodal NK/T-Cell lymphoma, nasal type: Retrospective study of 18 consecutive cases in Guangzhou, China

International Journal of Surgical Pathology

Volumn 19, Issue 1, 2011, Pages 51-61

  Huang, Yu Hua ^a,b   Wu, Qiu Liang ^a,c   Zong, Yong Sheng ^d   Feng, Yan Fen ^a,c   Hou, Jing Hui ^a,c  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b Shenzhen Second Hospital   (China)

^c SUN YAT SEN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

Author keywords

BamHI F fragment; clinicopathologic features; Epstein Barr virus; LMP1 gene; nasopharyngeal lymphoma

Indexed keywords

CD56 ANTIGEN; VIRUS ANTIBODY; VIRUS RNA;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CERVICAL LYMPH NODE; CHINA; CLINICAL ARTICLE; CLINICAL FEATURE; DNA SEQUENCE; EPSTEIN BARR VIRUS; FEMALE; GENE; GENE DELETION; GENE LOSS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IN SITU HYBRIDIZATION; LMP1 GENE; MALE; NASOPHARYNGEAL NK T CELL LYMPHOMA; NASOPHARYNX CARCINOMA; NK T CELL LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADULT; AGED; CHINA; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; GENOTYPE; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LYMPHOMA, EXTRANODAL NK-T-CELL; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL;

EID: 79551672503     PISSN: 10668969     EISSN: 19402465     Source Type: Journal    
DOI: 10.1177/1066896910388806     Document Type: Article

References (28)

1. Swerdlow SH, Campo E., Harris NL, et al. WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC ; 2008: 285-288.
2. Lung ML, Chang GC Detection of distinct Epstein-Barr virus genotypes in NPC biopsies from southern Chinese and Caucasians. Int J Cancer. 1992 ; 52: 34-37.
3. Lin SX, Zong YS, Zhang M., et al. Study of sequence variations of Epstein-Barr virus LMP1 gene in nasopharyngeal carcinoma [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2005 ; 34: 791-795.
4. Lin JC, Lin SC, Luppi M., et al. Geographic sequence variation of latent membrane protein 1 gene of Epstein-Barr virus in Hodgkin's lymphomas. J Med Virol. 1995 ; 45: 183-191.
5. Cheung MM, Chan JK, Lau WH, et al. Primary non-Hodgkin's lymphoma of the nose and nasopharynx: clinical features,tumor immunophenotype, and treatment outcome in 113 patients. J Clin Oncol. 1998 ; 16: 70-77.
6. Menarguez J., Mollejo M., Carrion R., et al. Waldeyer ring lymphomas. A clinicopathological study of 79 cases. Histopathology. 1994 ; 24: 13-22.
7. Ye YL, Zhou MH, Lu XY, Dai YR, Wu WX Nasopharyngeal and nasal malignant lymphoma: a clinicopathological study of 54 cases. Histopathology. 1992 ; 20: 511-516.
8. Barnes L., Eveson JW, Reichart P., Sidransky D. WHO Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Lyon, France: IARC ; 2005: 104-105.
9. Laskar S., Muckaden MA, Bahl G., et al. Primary non-Hodgkin's lymphoma of the nasopharynx: prognostic factors and outcome of 113 Indian patients. Leuk Lymphoma. 2006 ; 47: 2132-2139.
10. Li YX, Coucke PA, Li JY, et al. Primary non-Hodgkin's lymphoma of the nasal cavity: prognostic significance of paranasal extension and the role of radiotherapy and chemotherapy. Cancer. 1998 ; 83: 449-456.
11. Pals ST, de Gorter DJ, Spaargaren M. Lymphoma dissemination: the other face of lymphocyte homing. Blood. 2007 ; 110: 3102-3111.
12. Feng YF, Wu QL, Zong YS Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection. Ai Zheng. 2007 ; 26: 1170-1176.
13. Ng SB, Lai KW, Murugaya S., et al. Nasal-type extranodal natural killer/T-cell lymphomas: a clinicopathologic and genotypic study of 42 cases in Singapore. Mod Pathol. 2004 ; 17: 1097-1107.
14. Takeshita M., Yoshida K., Suzumiya J., et al. Cases of cutaneous and nasal CD56 (NCAM)-positivelymphoma in Japan have differences in immunohistology, genotype, and etiology. Hum Pathol. 1999 ; 30: 1024-1034.
15. Ko YH, Ree HJ, Kim WS, et al. Clinicopathologic and genotypic study of extranodal nasal-type natural killer/T-cell lymphoma and natural killer precursor lymphoma among Koreans. Cancer. 2000 ; 89: 2106-2116.
16. Tai YC, Kim LH, Peh SC High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract. Pathol Int. 2004 ; 54: 158-166.
17. Kuo TT, Shih LY, Tsang NM Nasal NK/T cell lymphoma in Taiwan: a clinicopathologic study of 22 cases, with analysis of histologic subtypes, Epstein-Barr virus LMP-1 gene association, and treatment modalities. Int J Surg Pathol. 2004 ; 12: 375-387.
18. Suzumiya J., Ohshima K., Takeshita M., et al. Nasal lymphomas in Japan: a high prevalence of Epstein-Barr virus type A and deletion within the latent membrane protein gene. Leuk Lymphoma. 1999 ; 35: 567-578.
19. Kim JE, Kim YA, Jeon YK, et al. Comparative analysis of NK/T-cell lymphoma and peripheral T-cell lymphoma in Korea: Clinicopathological correlations and analysis of EBV strain type and 30-bp deletion variant LMP1. Pathol Int. 2003 ; 53: 735-743.
20. Chiang AK, Wong KY, Liang AC, et al. Comparative analysis of Epstein-Barr virus gene polymorphisms in nasal T/ NK-cell lymphomas and normal nasal tissues: implications on virus strain selection in malignancy. Int J Cancer. 1999 ; 80: 356-364.
21. Nagamine M., Takahara M., Kishibe K., et al. Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK/T-cell lymphoma. Virus Genes. 2007 ; 34: 47-54.
22. Zhou XG, Sandvej K., Li PJ, et al. Epstein - Barr virus gene polymorphisms in Chinese Hodgkin's disease cases and healthy donors: identification of three distinct virus variants. J Gen Virol. 2001 ; 82: 1157-1167.
23. Cheung ST, Lo KW, Leung SF, et al. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int J Cancer. 1996 ; 66: 711-712.
24. Cheung ST, Leung SF, Lo KW, et al. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int J Cancer. 1998 ; 76: 399-406.
25. Tang YL, Lu JH, Cao L., et al. Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. Braz J Med Biol Res. 2008 ; 41: 110-116.
26. See HS, Yap YY, Yip WK, Seow HF Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and XhoI-loss is associated with type III nasopharyngeal carcinoma in Malaysia. World J Surg Oncol. 2008 ; 6: 18.
27. Han AJ, Zong YS, Zhang M., et al. Analysis of Epstein-Barr virus with BamHI "f" variant and XhoI-loss of LMP1 gene in nasopharyngeal carcinoma [in Chinese]. Zhonghua Bing Li Xue Za Zhi. 2003 ; 32: 534-538.
28. Wu SJ, Lay JD, Chen CL, Chen JY, Liu MY, Su IJ Genomic analysis of Epstein-Barr virus in nasal and peripheral T-cell lymphoma: a comparison with nasopharyngeal carcinoma in an endemic area. J Med Virol. 1996 ; 50: 314-321.